Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001279569-07-000249
Filing Date
2007-02-26
Accepted
2007-02-23 20:23:00
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10K aspreva10k.htm 10-K 2099949
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex231.htm EX-23.1 4284
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex311.htm EX-31.1 21219
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex312.htm EX-31.2 21294
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C SECTION 1350 ex321.htm EX-32.1 9021
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C SECTION 1350 ex322.htm EX-32.2 9182
7 EMPLOYMENT AGREEMENT ex1032.htm EX-10.32 251363
8 SCHEDULE B ex1033.htm EX-10.33 60844
  Complete submission text file 0001279569-07-000249.txt   2478562
Mailing Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8 (250) 744-2488
Aspreva Pharmaceuticals CORP (Filer) CIK: 0001314026 (see all company filings)

EIN.: 980435540 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51169 | Film No.: 07647374
SIC: 2834 Pharmaceutical Preparations